This is what I was hoping they would do if they had the opportunity.
Brickell (Fresh Track Therapeutics) has such a low market cap, why not buy them out? or if Brickell is in need of cash ASAP, then why not buy the future Royalties from them? Makes sense.
- Forums
- ASX - By Stock
- BOT
- Ann: Trading Halt
Ann: Trading Halt, page-27
-
- There are more pages in this discussion • 182 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
35.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $642.5M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 39.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
35.5¢ | 4395 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 0.390 |
1 | 1318 | 0.380 |
3 | 32550 | 0.365 |
3 | 66582 | 0.360 |
2 | 75000 | 0.355 |
Price($) | Vol. | No. |
---|---|---|
0.355 | 4395 | 2 |
0.360 | 43063 | 5 |
0.365 | 73950 | 4 |
0.370 | 254910 | 9 |
0.375 | 212000 | 2 |
Last trade - 09.55am 14/08/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online